HEAD AND NECK CANCERS - THROAT
Clinical trials for HEAD AND NECK CANCERS - THROAT explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS - THROAT trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS - THROAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called VMD-928, taken as a pill, either alone or with pembrolizumab (an immunotherapy), in adults with advanced solid tumors or lymphoma that have stopped responding to standard treatments. The goal is to find safe doses and see if the drug c…
Matched conditions: HEAD AND NECK CANCERS - THROAT
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New combo tackles returning head and neck cancer
Disease control Recruiting nowThis study is for people whose head and neck cancer has come back after previous treatment. It tests a new combination of drugs (tislelizumab and pamiparib) given together with chemotherapy and a second round of radiation. The main goal is to find the safest dose and see if this …
Matched conditions: HEAD AND NECK CANCERS - THROAT
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 04, 2026 16:24 UTC